Drugs Made In America Acquisition Corp. - Ordinary Shares, $0.0001 par value (DMAA)

Historical Holders from Q1 2025 to Q3 2025

Symbol
DMAA on Nasdaq
Type / Class
Equity / Ordinary Shares, $0.0001 par value
Shares outstanding
33,549,784
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
22,407,322
Holdings value
$230,112,841
% of all portfolios
0.001%
Number of holders
38
Number of buys
16
Number of sells
-14
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Drugs Made In America Acquisition Corp. - Ordinary Shares, $0.0001 par value (DMAA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Drugs Made In America Acquisition LLC 12.5% $42,139,127 4,188,780 Drugs Made In America Acquisition LLC 18 Feb 2025
Karpus Management, Inc. 8.19% +18% $27,989,912 +$4,284,765 2,744,109 +18.1% KARPUS MANAGEMENT, INC. 30 Jun 2025
First Trust Capital Management L.P. 6.17% $20,791,022 2,066,702 First Trust Capital Management L.P. 31 Mar 2025
Polar Asset Management Partners Inc. 5.7% $19,114,000 1,900,000 Polar Asset Management Partners Inc. 31 Mar 2025
GLAZER CAPITAL, LLC 5.44% $18,338,897 1,822,952 Glazer Capital, LLC 31 Mar 2025
Hudson Bay Capital Management LP 4.62% -15% $15,918,500 -$2,567,500 1,550,000 -13.9% Hudson Bay Capital Management LP 30 Sep 2025

Institutional Holders of Drugs Made In America Acquisition Corp. - Ordinary Shares, $0.0001 par value (DMAA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 22,407,322 $230,112,841 +$8,645,514 $10.27 38
2025 Q2 20,823,195 $212,304,432 +$35,784,995 $10.2 32
2025 Q1 16,949,502 $169,795,617 +$169,795,617 $10.02 23